Tempus AI, traded as TEM, is reportedly being analyzed by market watchers for its potential and valuation. Some outlets note that the company is leveraging ai for precision medicine advancements and building a strong presence in healthcare data. Meanwhile, there are also reports of investment activities, including share acquisitions and sales, by various entities and individuals associated with the company.